2 Heavyweight! First ADC Drug For Refractory Ovarian Cancer Receives Accelerated FDA Approval Mar 31, 2025
4 New Treatment For Uroepithelial Carcinoma Receives Fda Fast Track Designation With Encouraging Initial Results Mar 27, 2025
5 Pfizer's New Treatment Elranatamab Receives FDA Breakthrough Therapy Designation For Relapsed Or Refractory Multiple Myeloma Mar 24, 2025
6 Angry FDA & CDC: $5 Billion Bivalent Moderna New Crown Vaccine Not As Effective As Monovalent Mar 16, 2025
Read More Apparatus Heavyweight! First ADC Drug For Refractory Ovarian Cancer Receives Accelerated FDA Approval Mar 31, 2025
Read More Apparatus World's First Antibody Targeting B7H7 Approved For Clinical Trial In The Us Apr 02, 2025
Read More Apparatus New Lymphoma Drug Approved! Half Of The Patients Had Significant Tumour Regression Apr 09, 2025
Read More Apparatus World's 2nd KRAS Inhibitor Approved For Non-Small Cell Lung Cancer With 80% Efficacy! Apr 04, 2025
